Elizabeth Heritage Cull, MD
Fax: (864) 987-7020
About us
Elizabeth Cull, MD, is a physician specializing in medical oncology and hematology at Prisma Health Cancer Institute. She provides care and treatment for patients with benign and malignant blood disorders with emphasis on malignant disorders such as lymphoma, leukemia, and multiple myeloma including expertise in stem cell/bone marrow transplant.
Dr. Cull earned her medical degree from Wake Forest University School of Medicine in Winston-Salem, NC. She completed her internship, residency and Hematology Oncology Fellowship at the McGraw Medical Center of Northwestern University in Chicago. Dr. Cull is board certified in both Medical Oncology and Hematology. She is a member of the American Society of Clinical Oncology, the American Society of Hematology and the American Society of Bone Marrow Transplant.
Dr. Cull additionally manages the hematologic malignancy division of ITOR, the phase I clinical trial unit. She is also the co-director of the Adolescent and Young Adult Oncology program at Prisma Health.
| Tags | breast cancer immunotherapy, cancer, cancer during pregnancy, cancer genomics, cancer pain, hereditary cancer risk, cancer survivor, cancer related fatigue, cardio oncology, endocrine complications of cancer therapy, oral complications of cancer, pulmonary metastases, side effects of cancer treatment, liver metastases, skeletal metastasis, cancer genetics, myelodysplastic syndrome, post transplant lymphoproliferative disorder, pretransplant clearance, sarcoma, stem cell transplant, syngeneic transplant, transplant related infection, acute lymphoblastic leukemia (all), acute myelogenous leukemia (aml), allogeneic bone marrow transplant, amyloidosis, aplastic anemia, autologous bone marrow transplant, bone marrow transplant, chronic myelocytic leukemia, donor lymphocyte infusion, graft versus host disease, graft versus leukemia effect, hla typing, cancer immunotherapy, leukemia, lymphoma, multiple myeloma, mycosis fungoides |